Literature DB >> 22257950

The diverse and complex roles of NF-κB subunits in cancer.

Neil D Perkins1.   

Abstract

It is only recently that the full importance of nuclear factor-κB (NF-κB) signalling to cancer development has been understood. Although much attention has focused on the upstream pathways leading to NF-κB activation, it is now becoming clear that the inhibitor of NF-κB kinases (IKKs), which regulate NF-κB activation, have many independent functions in tissue homeostasis and normal immune function that could compromise the clinical utility of IKK inhibitors. Therefore, if the NF-κB pathway is to be properly exploited as a target for both anticancer and anti-inflammatory drugs, it is appropriate to reconsider the complex roles of the individual NF-κB subunits.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22257950     DOI: 10.1038/nrc3204

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  160 in total

1.  TAK1 suppresses a NEMO-dependent but NF-kappaB-independent pathway to liver cancer.

Authors:  Kira Bettermann; Mihael Vucur; Johannes Haybaeck; Christiane Koppe; Jörn Janssen; Felix Heymann; Achim Weber; Ralf Weiskirchen; Christian Liedtke; Nikolaus Gassler; Michael Müller; Rita de Vos; Monika Julia Wolf; Yannick Boege; Gitta Maria Seleznik; Nicolas Zeller; Daniel Erny; Thomas Fuchs; Stefan Zoller; Stefano Cairo; Marie-Annick Buendia; Marco Prinz; Shizuo Akira; Frank Tacke; Mathias Heikenwalder; Christian Trautwein; Tom Luedde
Journal:  Cancer Cell       Date:  2010-05-18       Impact factor: 31.743

2.  Identification of a tumor-associated mutant form of the NF-kappaB RelA gene with reduced DNA-binding and transactivating activities.

Authors:  D Trecca; L Guerrini; N S Fracchiolla; M Pomati; L Baldini; A T Maiolo; A Neri
Journal:  Oncogene       Date:  1997-02-20       Impact factor: 9.867

3.  The Catalogue of Somatic Mutations in Cancer (COSMIC).

Authors:  S A Forbes; G Bhamra; S Bamford; E Dawson; C Kok; J Clements; A Menzies; J W Teague; P A Futreal; M R Stratton
Journal:  Curr Protoc Hum Genet       Date:  2008-04

Review 4.  Posttranslational modifications of NF-kappaB: another layer of regulation for NF-kappaB signaling pathway.

Authors:  Bo Huang; Xiao-Dong Yang; Acacia Lamb; Lin-Feng Chen
Journal:  Cell Signal       Date:  2010-04-02       Impact factor: 4.315

5.  INK4 cell cycle inhibitors direct transcriptional inactivation of NF-kappaB.

Authors:  B Wolff; M Naumann
Journal:  Oncogene       Date:  1999-04-22       Impact factor: 9.867

6.  Opposing roles of NF-κB in anti-cancer treatment outcome unveiled by cross-species investigations.

Authors:  Hua Jing; Julia Kase; Jan R Dörr; Maja Milanovic; Dido Lenze; Michael Grau; Gregor Beuster; Sujuan Ji; Maurice Reimann; Peter Lenz; Michael Hummel; Bernd Dörken; Georg Lenz; Claus Scheidereit; Clemens A Schmitt; Soyoung Lee
Journal:  Genes Dev       Date:  2011-10-06       Impact factor: 11.361

Review 7.  Nuclear factor-kappaB: its role in health and disease.

Authors:  Ashok Kumar; Yasunari Takada; Aladin M Boriek; Bharat B Aggarwal
Journal:  J Mol Med (Berl)       Date:  2004-06-03       Impact factor: 4.599

8.  Mechanism of hypoxia-induced NF-kappaB.

Authors:  Carolyn Culver; Anders Sundqvist; Sharon Mudie; Andrew Melvin; Dimitris Xirodimas; Sonia Rocha
Journal:  Mol Cell Biol       Date:  2010-08-09       Impact factor: 4.272

9.  Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma.

Authors:  Etienne Meylan; Alison L Dooley; David M Feldser; Lynn Shen; Erin Turk; Chensi Ouyang; Tyler Jacks
Journal:  Nature       Date:  2009-10-21       Impact factor: 49.962

10.  Variants of the RELA gene are associated with schizophrenia and their startle responses.

Authors:  Ryota Hashimoto; Kazutaka Ohi; Yuka Yasuda; Motoyuki Fukumoto; Hidenaga Yamamori; Hidetoshi Takahashi; Masao Iwase; Tomo Okochi; Hiroaki Kazui; Osamu Saitoh; Masahiko Tatsumi; Nakao Iwata; Norio Ozaki; Kunitoshi Kamijima; Hiroshi Kunugi; Masatoshi Takeda
Journal:  Neuropsychopharmacology       Date:  2011-05-18       Impact factor: 7.853

View more
  387 in total

1.  Histone methyltransferase NSD2/MMSET mediates constitutive NF-κB signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop.

Authors:  Ping Yang; Linlang Guo; Zhijian J Duan; Clifford G Tepper; Ling Xue; Xinbin Chen; Hsing-Jien Kung; Allen C Gao; June X Zou; Hong-Wu Chen
Journal:  Mol Cell Biol       Date:  2012-05-29       Impact factor: 4.272

Review 2.  Regulation of cancer metabolism by O-GlcNAcylation.

Authors:  Zhonghua Li; Wen Yi
Journal:  Glycoconj J       Date:  2013-12-10       Impact factor: 2.916

3.  Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-κB regulation.

Authors:  Fuminori Tokunaga; Hiroshi Nishimasu; Ryuichiro Ishitani; Eiji Goto; Takuya Noguchi; Kazuhiro Mio; Kiyoko Kamei; Averil Ma; Kazuhiro Iwai; Osamu Nureki
Journal:  EMBO J       Date:  2012-08-28       Impact factor: 11.598

4.  cIAP2 represses IKKα/β-mediated activation of MDM2 to prevent p53 degradation.

Authors:  Rosanna Lau; Min Ying Niu; M A Christine Pratt
Journal:  Cell Cycle       Date:  2012-10-03       Impact factor: 4.534

5.  Activation of the NF-κB pathway by the STAT3 inhibitor JSI-124 in human glioblastoma cells.

Authors:  Braden C McFarland; G Kenneth Gray; Susan E Nozell; Suk W Hong; Etty N Benveniste
Journal:  Mol Cancer Res       Date:  2013-02-05       Impact factor: 5.852

6.  Inhibitors of NF-kappaB reverse cellular invasion and target gene upregulation in an experimental model of aggressive oral squamous cell carcinoma.

Authors:  Jeff Johnson; Zonggao Shi; Yueying Liu; M Sharon Stack
Journal:  Oral Oncol       Date:  2014-02-28       Impact factor: 5.337

7.  Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation.

Authors:  Yinghui Li; Qi-Ling Zhou; Wenjie Sun; Prashant Chandrasekharan; Hui Shan Cheng; Zhe Ying; Manikandan Lakshmanan; Anandhkumar Raju; Daniel G Tenen; Shi-Yuan Cheng; Kai-Hsiang Chuang; Jun Li; Shyam Prabhakar; Mengfeng Li; Vinay Tergaonkar
Journal:  Nat Cell Biol       Date:  2015-09-21       Impact factor: 28.824

8.  Betaglycan alters NFκB-TGFβ2 cross talk to reduce survival of human granulosa tumor cells.

Authors:  Maree Bilandzic; Simon Chu; Yao Wang; Han L Tan; Peter J Fuller; Jock K Findlay; Kaye L Stenvers
Journal:  Mol Endocrinol       Date:  2013-01-15

9.  A splicing variant of NME1 negatively regulates NF-κB signaling and inhibits cancer metastasis by interacting with IKKβ.

Authors:  Dong-Joo You; Cho Rong Park; Hyun Bok Lee; Mi Jin Moon; Ju-Hee Kang; Cheolju Lee; Seong-Hyun Oh; Curie Ahn; Jae Young Seong; Jong-Ik Hwang
Journal:  J Biol Chem       Date:  2014-05-08       Impact factor: 5.157

10.  Copper is a potent inhibitor of both the canonical and non-canonical NFκB pathways.

Authors:  Niall S Kenneth; George E Hucks; Andrew J Kocab; Annie L McCollom; Colin S Duckett
Journal:  Cell Cycle       Date:  2014-02-03       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.